Back to User profile » Dr Dawn Velligan
Papers published by Dr Dawn Velligan:
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
Haider B, O'Sullivan AK, Bessonova L, Keane E, Achtyes E, Harvey PD, Kane JM, Saklad SR, Trotter JP, Claxton A, Polak T, McGrory J, Noori W, Sikora Kessler A, Yarlas A, Velligan D
Neuropsychiatric Disease and Treatment 2023, 19:623-634
Published Date: 17 March 2023
Patient and Provider Perspectives on Medication Non-adherence Among Patients with Depression and/or Diabetes in Diverse Community Settings – A Qualitative Analysis
Hamilton JE, Blanco E, Selek S, Wirfel KL, Bernstam EV, Velligan D, Gudala M, Roberts K
Patient Preference and Adherence 2022, 16:1581-1594
Published Date: 30 June 2022
Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
Ruetsch C, Davis T, Liberman JN, Velligan DI, Robinson D, Jaeger C, Carpenter W, Forma F
Neuropsychiatric Disease and Treatment 2021, 17:3715-3726
Published Date: 16 December 2021
Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey
Doane MJ, Sajatovic M, Weiden PJ, O’Sullivan AK, Maher S, Bjorner JB, Sikora Kessler A, Carpenter-Conlin J, Bessonova L, Velligan DI
Patient Preference and Adherence 2020, 14:2043-2054
Published Date: 28 October 2020
Engagement-focused care during transitions from inpatient and emergency psychiatric facilities
Velligan DI, Fredrick M, Sierra C, Hillner K, Kliewer J, Roberts DL, Mintz J
Patient Preference and Adherence 2017, 11:919-928
Published Date: 12 May 2017
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP
Patient Preference and Adherence 2017, 11:449-468
Published Date: 3 March 2017